CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 50,099	$ 29,250
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	24,812	8,025
Amortization of deferred financing fees	628	295
Amortization of debt fair value adjustment	137	(60)
Amortization of restricted stock and restricted stock units	4,486	2,941
Equity in (earnings) loss of unconsolidated joint ventures	(1,895)	4,208
Equity in earnings on sale of real estate of unconsolidated ventures	(64,531)	(34,982)
Impairment charge	0	520
Gain on sale of real estate	(6)	(7,693)
Gain on sale of partnership interest	0	(2,632)
Gain on insurance recovery	(62)	0
Loss on extinguishment of debt	563	1,575
Increases and decreases from changes in other assets and liabilities:
Decrease in other assets	4,717	2,203
Decrease in accounts payable and accrued liabilities	(3,923)	(4,179)
Net cash provided by (used in) operating activities	15,025	(529)
Cash flows from investing activities:
Improvements to real estate owned	(6,295)	(1,308)
Purchase and consolidation of joint venture properties	(105,262)	(111,956)
Proceeds from the sale of real estate owned	4,385	24,632
Proceeds from the sale of joint venture interests	0	10,540
Distributions from unconsolidated joint ventures	91,239	62,025
Contributions to unconsolidated joint ventures	(3,500)	(6,031)
Proceeds from insurance recoveries	62	0
Net cash used in investing activities	(19,371)	(22,098)
Cash flows from financing activities:
Proceeds from mortgages payable	18,953	89,680
Mortgage payoffs	(41,666)	(47,605)
Mortgage principal payments	(2,219)	(2,688)
Proceeds from credit facility	43,000	0
Repayment of credit facility	(24,000)	0
Increase in deferred financing costs	(693)	(319)
Dividends paid	(17,863)	(15,769)
Distributions to non-controlling interests	(157)	(60)
Proceeds from the sale of common stock	9,945	9,624
Proceeds from the issuance of DRP shares	1,278	0
Net cash (used in) provided by financing activities	(13,422)	32,863
Net (decrease) increase in cash, cash equivalents and restricted cash:	(17,768)	10,236
Cash, cash equivalents and restricted cash at beginning of year	38,921	28,685
Cash, cash equivalents and restricted cash at end of year	21,153	38,921
Supplemental disclosures of cash flow information:
Cash paid during the year for interest expense	14,086	6,523
Cash paid during the year for income and excise taxes	283	173
Consolidation on buyout of partnership interest:
Increase in real estate assets	(370,513)	(160,583)
Increase in other assets	(17,489)	(5,671)
Increase in mortgage payable	231,896	29,067
Increase in deferred loan costs	(3,892)	(748)
Increase in accounts payable and accrued liabilities	6,278	2,621
Decrease in investment in unconsolidated joint ventures	48,458	23,358
Purchase and consolidation of investment in joint venture	(105,262)	(111,956)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	20,281	32,339
Restricted cash	872	6,582
Total cash, cash equivalents and restricted cash, shown in consolidated statement of cash flows	$ 21,153	$ 38,921